Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Sepsis peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Sepsis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
3 profiles.
2013–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 90 selected PubMed records and 46 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Sepsis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00942149
PeptideScanner retained ClinicalTrials.gov record NCT00942149 at 2026-11-15T22:01:45.056Z. Its registry update date was 2013-07-15, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- July 15, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02867267
PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 10, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02883595
PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 4, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Thymosin alpha-1 · 2026-11-06
ClinicalTrials.gov record NCT07922954
Active, not recruiting at the retained observation.
Open attributed record →Vasopressin · 2026-08-31
ClinicalTrials.gov record NCT06709573
Recruiting at the retained observation.
Open attributed record →Thymosin alpha-1 · 2023-04-10
ClinicalTrials.gov record NCT02867267
Completed at the retained observation.
Open attributed record →Thymosin alpha-1 · 2019-04-04
ClinicalTrials.gov record NCT02883595
Completed at the retained observation.
Open attributed record →Daptomycin · 2013-07-15
ClinicalTrials.gov record NCT00942149
Completed at the retained observation.
Open attributed record →